Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.52
22.07
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Accrued Liabilities
Shanghai Pharmaceuticals Holding Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Accrued Liabilities
¥10.9B
|
CAGR 3-Years
118%
|
CAGR 5-Years
72%
|
CAGR 10-Years
37%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Accrued Liabilities
¥35.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
21%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Accrued Liabilities
¥773.3m
|
CAGR 3-Years
53%
|
CAGR 5-Years
41%
|
CAGR 10-Years
21%
|
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Accrued Liabilities
¥187.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
4%
|
CAGR 10-Years
21%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Accrued Liabilities
¥445.3m
|
CAGR 3-Years
41%
|
CAGR 5-Years
26%
|
CAGR 10-Years
29%
|
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Accrued Liabilities
¥681.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
24%
|
CAGR 10-Years
18%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
Glance View
Shanghai Pharmaceuticals Holding Co Ltd, a giant in China's pharmaceutical industry, operates with a dual-engine strategy that seamlessly combines manufacturing and distribution. Established in the bustling metropolis of Shanghai, the company has swiftly become a cornerstone of China's healthcare landscape. Its manufacturing arm is a powerhouse of innovation and production, turning out a vast array of pharmaceutical products that encompass both traditional Chinese medicine and modern pharmaceuticals. These products range from patented medicines to essential generics, entering hospitals, clinics, and retail pharmacies nationwide, all the while feeding a robust supply chain that caters to the country's vast and diverse market needs. On the flip side, Shanghai Pharmaceuticals' extensive distribution network is the lifeline that ensures these vital medicines reach their destinations safely and efficiently. In an era where logistics and supply chain management are pivotal, the company excels through an advanced distribution system that connects manufacturers with end-users across China. This network is bolstered by strategic partnerships and a commitment to technological advancement, allowing the company to maintain agility and reliability in an ever-evolving market. Revenue streams flow not just from product sales but are heavily supplemented through strategic partnerships and services that enhance accessibility and affordability for healthcare providers and patients alike. As one of the top pharmaceutical firms in China, Shanghai Pharmaceuticals is adept at maneuvering the intricacies of healthcare demands, regulatory landscapes, and competitive dynamics, carving its niche as a leader in both innovation and distribution efficiency.
See Also
What is Shanghai Pharmaceuticals Holding Co Ltd's Accrued Liabilities?
Accrued Liabilities
10.9B
CNY
Based on the financial report for Sep 30, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Accrued Liabilities amounts to 10.9B CNY.
What is Shanghai Pharmaceuticals Holding Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
37%
Over the last year, the Accrued Liabilities growth was 682%. The average annual Accrued Liabilities growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been 118% over the past three years , 72% over the past five years , and 37% over the past ten years .
You don't have any saved screeners yet